NO973732D0 - Anvendelse av hyaluronsyre for behandling av interstitiell cyctit - Google Patents

Anvendelse av hyaluronsyre for behandling av interstitiell cyctit

Info

Publication number
NO973732D0
NO973732D0 NO973732A NO973732A NO973732D0 NO 973732 D0 NO973732 D0 NO 973732D0 NO 973732 A NO973732 A NO 973732A NO 973732 A NO973732 A NO 973732A NO 973732 D0 NO973732 D0 NO 973732D0
Authority
NO
Norway
Prior art keywords
hyaluronic acid
interstitial
cyctite
treatment
interstitial cystitis
Prior art date
Application number
NO973732A
Other languages
English (en)
Other versions
NO973732L (no
NO315842B1 (no
Inventor
Alvaro Morales
Stanley J Alkemade
Original Assignee
Bioniche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc filed Critical Bioniche Inc
Publication of NO973732D0 publication Critical patent/NO973732D0/no
Publication of NO973732L publication Critical patent/NO973732L/no
Publication of NO315842B1 publication Critical patent/NO315842B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19973732A 1995-02-14 1997-08-13 Anvendelse av hyaluronsyre for fremstilling av en farmasöytisk blanding NO315842B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US59101596A 1996-02-08 1996-02-08
PCT/CA1996/000094 WO1996025168A1 (en) 1995-02-14 1996-02-14 Use of hyaluronic acid for the treatment of interstitial cystitis

Publications (3)

Publication Number Publication Date
NO973732D0 true NO973732D0 (no) 1997-08-13
NO973732L NO973732L (no) 1997-10-10
NO315842B1 NO315842B1 (no) 2003-11-03

Family

ID=27012116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973732A NO315842B1 (no) 1995-02-14 1997-08-13 Anvendelse av hyaluronsyre for fremstilling av en farmasöytisk blanding

Country Status (20)

Country Link
US (1) US5888986A (no)
EP (1) EP0813417B1 (no)
JP (1) JP4354528B2 (no)
KR (1) KR100268660B1 (no)
CN (1) CN1181016A (no)
AT (1) ATE247476T1 (no)
AU (1) AU705289B2 (no)
BR (1) BR9607601A (no)
CA (1) CA2203621C (no)
CZ (1) CZ288218B6 (no)
DE (1) DE69629553T2 (no)
DK (1) DK0813417T3 (no)
ES (1) ES2205013T3 (no)
HU (1) HUP9800467A3 (no)
IN (1) IN181358B (no)
NO (1) NO315842B1 (no)
NZ (1) NZ300903A (no)
PT (1) PT813417E (no)
TR (1) TR199700782T1 (no)
WO (1) WO1996025168A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2268476A1 (en) 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
US6548487B2 (en) 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
CA2247389C (en) * 1996-12-27 2009-11-24 Seikagaku Corporation Agent for treatment of bladder troubles
DE69916643T2 (de) * 1998-10-22 2005-04-28 Bioniche Life Sciences Inc., London Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
MXPA02005842A (es) * 1999-12-13 2003-10-14 Bioniche Life Sciences Inc Oligonucleotidos sinteticos terapeuticamente utiles.
JP4215429B2 (ja) * 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
EP3556360A1 (en) * 2005-01-14 2019-10-23 Urigen, Inc. Compositions for treating lower urinary tract disorders
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
EP2545925B1 (en) 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
CN103655601B (zh) * 2013-12-31 2019-10-25 上海建华精细生物制品有限公司 一种用于膀胱灌洗的组合物
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
WO2015154007A1 (en) * 2014-04-03 2015-10-08 Lipella Pharmaceuticals, Inc. Systems and methods of detecting interstitial cystitis
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
JP2995090B2 (ja) * 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ 組織増大のための組成物および方法

Also Published As

Publication number Publication date
JPH10513476A (ja) 1998-12-22
JP4354528B2 (ja) 2009-10-28
DE69629553D1 (de) 2003-09-25
CZ288218B6 (en) 2001-05-16
US5888986A (en) 1999-03-30
CA2203621C (en) 1998-04-28
NZ300903A (en) 1999-07-29
HUP9800467A3 (en) 1999-01-28
WO1996025168A1 (en) 1996-08-22
CN1181016A (zh) 1998-05-06
PT813417E (pt) 2003-12-31
AU705289B2 (en) 1999-05-20
MX9706182A (es) 1998-07-31
ATE247476T1 (de) 2003-09-15
KR100268660B1 (ko) 2000-10-16
HUP9800467A2 (hu) 1998-06-29
NO973732L (no) 1997-10-10
CZ257497A3 (cs) 1998-01-14
TR199700782T1 (xx) 1998-03-21
AU4617996A (en) 1996-09-04
EP0813417A1 (en) 1997-12-29
KR19980702251A (ko) 1998-07-15
DE69629553T2 (de) 2004-06-17
DK0813417T3 (da) 2003-11-03
EP0813417B1 (en) 2003-08-20
BR9607601A (pt) 1999-09-14
IN181358B (no) 1998-05-30
CA2203621A1 (en) 1996-08-22
ES2205013T3 (es) 2004-05-01
NO315842B1 (no) 2003-11-03

Similar Documents

Publication Publication Date Title
NO973732L (no) Anvendelse av hyaluronsyre for behandling av interstitiell cyctit
ZA988278B (en) Ionic polymers as toxin-binding agents
GB9807639D0 (en) Anti-inflammatory agents
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
WO2002056895A3 (en) Ionene polymers and their use in treating mucositis
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
BR9912599A (pt) Agentes colinérgicos no tratamento da presbiopia
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
PL338071A1 (en) Treatment of intestinal and vesical inflammatory disorders
DE69721747D1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
ATE264674T1 (de) Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
ATE249225T1 (de) Mannose-6-phosphat enthaltendes mittel und dessen verwendung bei der behandlungfibrotischer erkrankungen
DE69835210D1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen
RU97115451A (ru) Способ лечения интерстициального цистита
ZA984433B (en) Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas
ATE224729T1 (de) Verwendung von hyaluronidase
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
RU93053600A (ru) Способ лечения хронических воспалительных заболеваний поджелудочной железы
RU93002661A (ru) Способ склерозирования вен при варикозе
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией

Legal Events

Date Code Title Description
MK1K Patent expired